The 31st Annual Meeting and Symposium of The Korean Society of Applied Pharmacology

Exploring Novel Therapeutic Approaches for Intractable Diseases through Organoid Models

October 6 (Fri), 2023 2F Mugunghwa Hall
Time Program Chair
09:00~ Registration
09:20~09:30 Opening Remarks
Greeting from President of KSAP
Hyun-Jeong Ko
(Kangwon National University)
SessionⅠ. Basic Understanding of Organoids in Drug Development Se-Ran Yang
(Kangwon National University)
09:30~09:55 Organoids: A new Platform in basic and Translational Research
Ji Hun Yang, Next and Bio Inc.
09:55~10:20 Liver Organoid Platform for Disease Modeling and Safety Assessment
Myung Jin Son, Korea Research Institute of Bioscience and Biotechnology
10:20~10:45 Patient-derived organoids as a platform for drug screening
Minsuh Kim, Korea University
10:45~11:00 Coffee Break
Session Ⅱ. Organoids as Disease Models for Innovative Drug Development Hyuk-Jin Cha
(Seoul National University)
11:00~11:25 Vascularized liver organoids from human induced pluripotent stem cells: disease modeling & drug screening
Jong-Hoon Kim, Korea University
11:25~11:50 Stem Cell-based Therapy of Ischemic Diseases
Jae Ho Kim, Pusan National University
11:50~12:15 Dissecting cellular heterogeneity and plasticity of gastric stem cells
Jong Kyoung Kim, POSTECH
12:15~13:30 Lunch & Poster Session
Plenary Lecture Hyun-Jeong Ko
(Kangwon National University)
13:30~14:05 CRISPR/Cas-assisted genetics in intestinal organoids
Bon-Kyoung Koo, Institute for Basic Science
Session Ⅲ. Innovative Drug Development for Neurodegenerative Diseases Soo Young Kim
(Yeungnam University)
14:05~14:30 Anti-Amyloidogenic Effect of a Novel RAGE Modulator
Dong-Gyu Jo, Sungkyunkwan University
14:30~14:55 Amyloid Against Amyloid: Dimeric Amyloid Fragment Ameliorates Cognitive Impairments by Direct Clearance of Oligomers and Plaques
YoungSoo Kim, Yonsei University
14:55~15:20 Cdk4/6 inhibitor modulates AD pathology, neuroinflammation and cognitive function in a mouse model of AD
Hyang-Sook Hoe, KBRI
15:20~15:35 Coffee Break
Session IV. Novel Anti-Cancer Drug Development Hyungshin Yim
(Hanyang University)
15:35~16:00 Tyrosine kinase-targeting strategies to overcome intractable cancer
Keon Wook Kang, Seoul National University
16:00~16:25 Novel immunotherapeutic approach using engineered T cell-derived extracellular vesicles
Moon-Chang Baek, Kyungpook National University.
16:25~16:50 The impact of ZEB1-modulated hyaluronan network on lung cancer metastasis
Young-Ho Ahn, Ewha Womans University
17:00~17:25 Academic Research Award Lecture Chan Young Shin
(Konkuk University)
17:30~18:00 General Assembly Tae Jin Kang
(Sahmyook University)

October 6 (Fri), 2023 1F Magnolia Hall
Time Program Chair
Session Ⅴ. Outstanding Young Investigators Kwang Hun Chun
(Gachon University)
Byung-Seok Kim
(Incheon National University)
09:30~09:50 Acetylated tau: A missing link between brain injury and Alzheimer’s disease
Min-Kyoo Shin, Seoul National University
09:50~10:10 The role of transcriptional repressor Capicua (CIC) in cancer progression
Jiwon Kim, Jeju National University
10:10~10:30 Leveraging transcriptomic signatures and network models to uncover cancer resistance and muscle atrophy
Sang-Min Park, Chungnam National University
10:30~10:50 Enhancer activation, Release and Re-targeting in transcription
Soohwan Oh, Korea University
10:50~11:10 A non-canonical role for NMDA receptors associated with the antidepressant action of ketamine
Ji-Woon Kim, Kyung Hee University
11:10~11:25 Coffee Break
Session Ⅵ. JSSX-KSAP Joint Symposium Pil-Hoon Park
(Yeungnam University)
11:25~11:50 Artificial Intelligence assisted early drug discovery & current drug pipelines
Mi-hyun Kim, Gachon University
11:50~12:15 Current and future application of organoid for drug safety evaluation
Tadahiro Shinozawa, Takeda Pharmaceutical Company
12:15~12:40 Next generation quantitative proteomics opens up the new fields of central nervous system barrier studies
Yasuo Uchida, Hiroshima University
12:40~13:30 Lunch & Poster Session
Session VII. Current Research on Drug Dependence: Academics and Government View Seikwan Oh
(Ehwa Womans University)
13:30~14:00 Application of machine intelligence for drug development and preclinical study
Daesoo Kim, KAIST
14:00~14:25 Interaction between miR-137 and SYNCRIP for the theragnosis of methamphetamine abstinence: from animals to human
Heh-In Im, KIST
14:25~14:50 Evaluation of microdialysis and drug discrimination test on seven NPS in rodents
Chan Hyeok Kwon, Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation
14:50~15:10 Coffee Break
15:10~15:35 Assessment of psychological and physical dependence of psychoactive drugs
Choon-Gon Jang, Sungkyunkwan University
Jaesuk Yun
(Chungbuk National University)
15:35~16:00 Risk assessment of the central nervous system effects and the abuse potential of new psychoactive substances
Su-Jeong Park, Pharmacological Research Division, National Institute of Food and Drug Safety Evaluation
16:00~16:25 Preclinical evaluations of the abuse potential of new drugs
Seong Shoon Yoon, Daegu Haany University
16:25~ Closing Remark

Poster Session

October 6 (Fri), 2023 1F Suryun · Dongbaek Hall
Time Program
09:30~10:30 Poster Set-up
13:00~13:30 Poster Presentation
16:00~17:00 Poster Removal
서울시 강남구 테헤란로7길 22 과학기술회관 1관 309호
TEL : 02-565-2167,  FAX : 02-584-2167,
Copyright (c) 2016 by KSAP All Rights Reserved.